Insmed invests heavily in a robust pipeline with multi-billion potential, positioning for future growth. Check out why INSM ...

Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

Akeso Inc. scored U.S. FDA approval of the PD-1 monoclonal antibody penpulimab in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or ...

With allergy season in full swing, Dr. Purvi Parikh joins Saturday TODAY to break down why many may be experiencing worse ...